Results 201 to 210 of about 127,159 (238)
Some of the next articles are maybe not open access.

Bioinformatics and Mutations Leading to Exon Skipping

2012
Our knowledge about human genes and the consequences of mutations leading to human genetic diseases has drastically improved over the last few years. It has been recognized that many mutations are indeed pathogenic because they impact the mRNA rather than the protein itself.
Desmet, François-Olivier   +1 more
openaire   +2 more sources

Exon-skipping therapy for Duchenne muscular dystrophy

The Lancet, 2009
Duchenne muscular dystrophy (DMD) is a lethal muscle disorder caused by mutations in the DMD gene for which no mutation‐targeted therapy has been available thus far. However, exon‐skipping mediated by antisense oligonucleotides (AOs), which are short single‐strand DNAs, has considerable potential for DMD therapy, and clinical trials in DMD patients are
Akinori, Nakamura, Shin'ichi, Takeda
openaire   +3 more sources

Overview on DMD Exon Skipping

2012
Antisense-mediated exon skipping to restore the disrupted dystrophin reading frame is currently in clinical trials for Duchenne muscular dystrophy. This chapter describes the rationale of this approach and gives an overview of in vitro and in vivo experiments with antisense oligonucleotides and antisense genes.
openaire   +4 more sources

A BRCA1 Nonsense Mutation Causes Exon Skipping [PDF]

open access: yesAmerican Journal of Human Genetics, 1998
The authors would like to thank the family members. We also thank C. Bonnardel, L. Boutrand, T. Conway, J. Lynch, S. Slominski, and P. Watson, for their expert assistance. This work was supported by program grants from le Comite Departemental de l'Ain de La Ligue contre le Cancer, the Council for Tobacco Research (grant 127DR@), the U.S.
Nadine PUGET   +2 more
exaly   +3 more sources

The association of nonsense codons with exon skipping

Mutation Research/Reviews in Mutation Research, 1998
Some genes that contain premature nonsense codons express alternatively-spliced mRNA that has skipped the exon containing the nonsense codon. This paradoxical association of translation signals (nonsense codons) and RNA splicing has inspired numerous explanations. The first is based on the fact that premature nonsense codons often reduce mRNA abundance.
openaire   +2 more sources

Induced dystrophin exon skipping in human muscle explants

open access: yesNeuromuscular Disorders, 2006
Antisense oligonucleotide (AO) manipulation of pre-mRNA splicing of the dystrophin gene is showing promise in overcoming Duchenne muscular dystrophy (DMD)-causing mutations.
Sue Fletcher   +2 more
exaly   +1 more source

Overview on Applications of Antisense-Mediated Exon Skipping

2012
Antisense-mediated exon skipping has multiple therapeutic applications. This chapter gives an overview of how this tool has been employed to restore normal splicing for cryptic splicing mutations, to switch between alternative splicing isoforms, to induce exon inclusion, to correct the reading frame to allow the production of internally deleted ...
Willeke M C, van Roon-Mom   +1 more
openaire   +2 more sources

Overview of Alternative Oligonucleotide Chemistries for Exon Skipping

2012
The chemistry of the oligonucleotide backbone is crucial to obtaining high activity in vivo in exon skipping applications. Apart from the ability to bind strongly and sequence-specifically to pre-mRNA targets, the type of backbone also influences cell delivery, in vivo pharmacology, bio-distribution, toxicology, and ultimately the therapeutic use in ...
Amer F, Saleh   +2 more
openaire   +2 more sources

Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy

Proceedings of the National Academy of Sciences of the United States of America, 2022
Md Nur Ahad Shah   +2 more
exaly  

Exon 44 skipping in Duchenne muscular dystrophy: NS-089/NCNP-02, a dual-targeting antisense oligonucleotide

Molecular Therapy - Nucleic Acids, 2023
Tetsuya Nagata   +2 more
exaly  

Home - About - Disclaimer - Privacy